Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Themis Medicare Limited (NSE: THEMISMED), ISIN INE083B01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
THEMISMED last traded at ₹103.30 (+2.70%), with a 52-week range of ₹64.95 to ₹140.60 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 67.11%, FIIs 0.01%, DIIs 0.01%, mutual funds 0.00%.
EquiSense Score (ECS): 15/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.